"ecoATM has an exciting and unique business model which provides lasting benefit to retailers, consumers and the environment," said Mr. Tullie. "I look forward to working with Mark and the team to propel the company towards achieving its maximum potential."

In related management changes, founder and CEO Mark Bowles will transition to Chief Marketing Officer (CMO) responsible for strategy, innovation and business development. Eric Rosser, formerly Vice President, Sales and Marketing, will move to a full-time focus on sales.

Mr. Bowles said, "Anyone who has worked with Tom Tullie, as I have in the past, understands the intense focus and leadership he brings to an organization. We are delighted he has agreed to take the helm as we ramp into the next phase."

Coinstar's Next Big Idea Award

Coinstar evaluated qualified entries to the Next Big Idea contest based on, among other things, the best solution for a consumer and/or retailer, potential market size and growth, originality and practicality. Mark Bowles, founder and CMO of ecoATM, accepted Coinstar's $10,000 award during a ceremony at the KioskCom self-service expo event held at the Jacob K. Javits Convention Center in New York City, N.Y. "ecoATM addresses a unique consumer, retailer, and environmental problem, and this recognition by Coinstar is a great honor and a validation of our concept," said Mr. Bowles.

About ecoATM

Based in San Diego, CA, ecoATM (http://www.ecoATM.com) provides a convenient in-store trade-in solution that benefits consumers, electronics retailers, and consumer electronics manufacturers. ecoATM is the only company to develop patent-pending, automated eCycling stations that electronically and/or visually inspect virtually any consumer electronic device, connect them with secondary market buyers and recyclers through pre-auction/auction systems, and administer trade-in promotions for retailers and manufacturers.

Logo: http://www.ereleases.com/pr/ecoATM-logo.jpg

    Media contact:

    Anita Giani
    650.743.0870

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE ecoATM Inc.

http://www.ecoATM.com

The area between the cash register and the front door is undervalued and therefore underutilized space representing an untapped opportunity for retailers. Discovering the potential of the 4th Wall is Coinstar's vision for offering an analytical process and expertise to maximize profit through front-end operations. If managed effectively, this area is estimated to generate five to ten times the industry average for net profitability per square foot.

Progressive Grocer Magazine is the leading trade publication for the food and beverage industry, and their annual award recognizes the best and most innovative companies in category management. The award is the highest mark of distinction presented by the magazine. Several factors were reviewed during the judging process, including product innovation, consumer insights, dynamic category management tools, and demonstrated commitment to meeting retail customers' specific needs. Complete coverage on Coinstar and the Category Captain awards can be found in Progressive Grocer's November/December 2009 issue or online at www.progressivegrocer.com.

About Coinstar, Inc.

Coinstar, Inc. (NASDAQ:CSTR), is a leading provider of automated retail solutions offering convenient products and services that make life easier for consumers and drive incremental traffic and revenue for its retailers. The Company's core automated retail businesses are self-service coin counting and self-service DVD rental. Other Coinstar products and services include e-payment products -- such as gift cards, prepaid debit cards and other prepaid products -- and money transfer services. The Company's products and services can be found at more than 90,000 points of presence including supermarkets, drug stores, mass merchants, financial institutions, convenience stores, restaurants, and money transfer agents. For more information, visit www.coinstar.com.

SOURCE: Coinstar, Inc.

Coinstar, Inc. 
Media Contact: 
Sarah Jones, 425-943-8121 
sjones@coinstar.com

Go to www.mysmartrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

In a press release out on November 16, Interactive Intelligence Releases Interaction SIP Station(TM)

New Communications Device Offers Affordable, Reliable and Simple Alternative to IP Desk Phones

INDIANAPOLIS, Nov 16, 2009 -- Interactive Intelligence (Nasdaq: ININ), a global provider of unified IP business communications solutions, is releasing the Interaction SIP Station(TM), a new communications endpoint device designed as an affordable, reliable and simple alternative to IP desk phones.

About Interactive Intelligence

Interactive Intelligence Inc. (Nasdaq: ININ) is a global provider of unified business communications solutions for contact center automation, enterprise IP telephony, and business process automation. The company was founded in 1994 and has approximately 3,000 customers worldwide. Interactive Intelligence is among Software Magazine's top 500 global software and services suppliers, is ranked among Network World's top 200 North American networking vendors, is a BusinessWeek "hot growth 50" company, and is among Fortune Small Business magazine's top 100 fastest growing companies. The company is also positioned in the leaders' quadrant of the Gartner 2008 Contact Center Infrastructure, Worldwide Magic Quadrant report. Interactive Intelligence employs more than 600 people and is headquartered in Indianapolis, Indiana. It has six global corporate offices with additional sales offices throughout North America, Latin America, Europe, Middle East, Africa and Asia Pacific. Interactive Intelligence can be reached at +1 317.872.3000 or info@inin.com; on the Net: www.inin.com.

Coinstar, Inc. (NASDAQ:CSTR) trading at $27.65 per share on trading volume of 46,103 shares.

In a press release out on November 16, Coinstar Receives Distinguished Category Captain Award for Fourth Consecutive Year

4th Wall Category Management Program Selected by Progressive Grocer Magazine

BELLEVUE, Wash., Nov 16, 2009 -- Coinstar, Inc. (NASDAQ:CSTR), today announced that Progressive Grocer Magazine has awarded Coinstar, Inc., the Category Captain award for "other perimeter" in the nonfood category. For the fourth year in a row, the Coinstar 4th Wall(R) category management program has been recognized by Progressive Grocer Magazine for lifting sales in the entire category.

About Coinstar, Inc.

Coinstar, Inc. (NASDAQ:CSTR), is a leading provider of automated retail solutions offering convenient products and services that make life easier for consumers and drive incremental traffic and revenue for its retailers. The Company's core automated retail businesses are self-service coin counting and self-service DVD rental. Other Coinstar products and services include e-payment products -- such as gift cards, prepaid debit cards and other prepaid products -- and money transfer services. The Company's products and services can be found at more than 90,000 points of presence including supermarkets, drug stores, mass merchants, financial institutions, convenience stores, restaurants, and money transfer agents. For more information, visit www.coinstar.com.

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) trading at $19.51 on a volume of 15,748 shares

In a press release out on November 16, Hi-Tech Pharmacal's ECR Subsidiary Signs Exclusive Agreement to Commercialize Sleep Aid in Oral Spray Form

AMITYVILLE, N.Y., Nov 16, 2009 -- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today the signing of an exclusive licensing agreement between Hi-Tech's ECR Pharmaceuticals subsidiary and NovaDel Pharma, Inc., a drug development company, through which ECR obtained the rights to market zolpidem tartrate oral spray, 5mg per spray, in the United States and Canada. Under the terms of the agreement ECR paid NovaDel $3 million upon closing. In addition NovaDel will receive a royalty of up to 15% on net sales, and a milestone payment if net sales reach a specific level in a calendar year.

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hi-Tech's ECR Pharmaceuticals subsidiary markets branded prescription products.

Seattle Genetics, Inc. (Nasdaq: SGEN) trading at $9.67 on a volume of 41,712 shares

In a press release out on November 16, Seattle Genetics Initiates Phase I Clinical Trial of Antibody-Drug Conjugate SGN-75

BOTHELL, Wash., Nov 16, 2009 -- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has initiated a phase I clinical trial of SGN-75 for metastatic renal cell carcinoma and relapsed and refractory non-Hodgkin lymphoma. SGN-75 is an antibody-drug conjugate (ADC) targeting CD70 that utilizes the company's proprietary technology.

About Seattle Genetics

Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company's lead product candidate, brentuximab vedotin (SGN-35), is in a pivotal trial under a special protocol assessment with the FDA. Brentuximab vedotin is empowered by Seattle Genetics' proprietary ADC technology comprising highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. In addition, Seattle Genetics has four other product candidates in ongoing clinical trials: lintuzumab (SGN-33), dacetuzumab (SGN-40), SGN-70 and SGN-75. Dacetuzumab is being developed under a worldwide collaboration with Genentech (a wholly-owned member of the Roche Group). Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Genentech, Bayer, CuraGen, a subsidiary of Celldex Therapeutics, Progenics, Daiichi Sankyo, MedImmune, a subsidiary of AstraZeneca, and Millennium: The Takeda Oncology Company, as well as an ADC co-development agreement with Agensys, a subsidiary of Astellas Pharma. More information can be found at www.seattlegenetics.com.

Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.

Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at info@Xtremepicks.com Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm

CONTACT: Xtremepicks.com e-mail: Info@xtremepicks.com WWW: http://www.Xtremepicks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.